Name | DIG NHS |
---|---|
Synonyms |
MFCD02093394
dig-nhs-ester Card-20(22)-enolide, 3-(2-((6-((2,5-dioxo-1-pyrrolidinyl)oxy)-6-oxohexyl)amino)-2-oxoethoxy)-12,14-dihydroxy-, (3β,5β,12β)- Card-20(22)-enolide, 3-[2-[[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl]amino]-2-oxoethoxy]-12,14-dihydroxy-, (3β,5β,12β)- ε-(Digoxigenin-3-0-acetamido)caproic acid N-hydroxysuccinimide ester (3β,5β,12β)-3-[2-({6-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl}amino)-2-oxoethoxy]-12,14-dihydroxycard-20(22)-enolide DIG NHS Digoxigenin NHS-ester (3β,5β,12β)-3-(2-((6-((2,5-Dioxo-1-pyrrolidinyl)oxy)-6-oxohexyl)amino)-2-oxoethoxy)-12,14-dihydroxycard-20(22)-enolide |
Description | Digoxigenin NHS ester is an activated ester which readily reacts with amino groups under mild conditions, attaching the digoxigenin (HY-B1025) moiety to proteins or amino-. Digoxigenin NHS ester can be used to label proteins and oligonucleotides[1][2]. |
---|---|
Related Catalog | |
References |
[2]. Dalia BURZYN, et al. Extracellular vesicle-aso constructs targeting stat6. Patent, WO2021030776A1. |
Density | 1.3±0.1 g/cm3 |
---|---|
Molecular Formula | C35H50N2O10 |
Molecular Weight | 658.78 |
Exact Mass | 658.346558 |
LogP | -0.25 |
Index of Refraction | 1.594 |
Storage condition | 20°C |
Hazard Codes | T |
---|---|
Risk Phrases | 26/27/28-33 |
Safety Phrases | 28-36/37-45 |